ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 689857 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 689857; 2) Community: the network communities that were significantly associated with the response to NSC 689857; 3) Molecule: the relationships between components within communities and NSC 689857; 4) MDR: the compounds that were significantly associated with the NSC 689857.

NSC Compound Enrichment Correlation
NSC 711077 Null 0.0135714101922724 0.13459739
NSC 727113 Null 0.0135714101922724 0.16384479
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0135714101922724 0.57814744
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0135714101922724 0.20913677
NSC 673464 Null 0.0139796580235792 0.31817753
NSC 683515 Null 0.0139796580235792 0.35971408
NSC 719407 Null 0.0139796580235794 0.11075225
NSC 724635 4,11-dihydroxy-1-(4-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl] amino}butyl)-1H-naphtho[2,3-f]indole-5,10-dione 0.0139796580235794 0.08559755
NSC 730507 Null 0.0139796580235794 -0.1258971
NSC 741291 6-(3-hydroxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one 0.0139796580235794 0.36512093
Total:36  Current:9    [First] [Prev] [Next] [Last]